Any company is a would be candidate for a buyout if the price is right. Imo at this stage the company is grossly underpriced, a matter which will be duly corrected in the coming months.
With FDA approval (if) the fair price should be no less than $35.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.